Ministry of Commerce slaps anti-dumping duty on Chinese medicine ofloxacin
The Commerce Department has recommended imposing an anti-dumping duty on Chinese ofloxacin – a medicine used to treat certain infections – for five years to protect domestic players from cheap imports from the neighboring country.
The Directorate of Trade Remedies (DGTR) has recommended the duty on imports of “ofloxacin” and its intermediates from China after finding in its investigation that the product was exported at dumped prices to India, which which had an impact on the national industry.
“The authority deems it necessary and recommends the imposition of the anti-dumping duty for a period of 5 years,” the management said in a notification. Ofloxacin is used to treat certain infections, including bronchitis, pneumonia, and infections of the skin, bladder, urinary tract, and prostate.
The DGTR had carried out the investigation following a complaint from Aarti Drugs Ltd regarding the dumping and the initiation of the investigation.
Management is under the ministry.
The recommended duty ranges from $0.53 per kilogram to $7.03 per kilogram. The Ministry of Finance takes the last call to impose these duties.
The imposition of anti-dumping duties is permitted under the World Trade Organization (WTO) regime.
The law aims to ensure fair trade practices and create a level playing field for domestic producers vis-à-vis foreign producers and exporters.
Additionally, the Revenue Department said the government decided not to extend anti-dumping duties on “textured, coated and uncoated tempered glass” from China, as recommended by the DGTR.
In May, the management recommended maintaining anti-dumping duties on Chinese solar glass for two years to protect domestic players from cheap imports.
(This story has not been edited by the Devdiscourse team and is auto-generated from a syndicated feed.)